1. Home
  2. COUR vs PCRX Comparison

COUR vs PCRX Comparison

Compare COUR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.32

Market Cap

932.9M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
PCRX
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
932.9M
1.0B
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
COUR
PCRX
Price
$5.32
$23.50
Analyst Decision
Buy
Strong Buy
Analyst Count
15
4
Target Price
$10.53
$30.25
AVG Volume (30 Days)
6.6M
516.5K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
39.22
107.44
EPS
N/A
0.07
Revenue
$757,500,000.00
$541,533,000.00
Revenue This Year
$9.43
$6.78
Revenue Next Year
$6.40
$8.54
P/E Ratio
N/A
$336.29
Revenue Growth
9.04
26.04
52 Week Low
$5.00
$18.80
52 Week High
$13.56
$27.64

Technical Indicators

Market Signals
Indicator
COUR
PCRX
Relative Strength Index (RSI) 44.26 49.85
Support Level $5.09 $22.13
Resistance Level $6.41 $24.20
Average True Range (ATR) 0.31 1.02
MACD -0.05 -0.06
Stochastic Oscillator 22.62 42.93

Price Performance

Historical Comparison
COUR
PCRX

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: